...
首页> 外文期刊>Canadian Journal of Veterinary Research >The effects of oral administration of Yunnan Baiyao on blood coagulation in beagle dogs as measured by kaolin-activated thromboelastography and buccal mucosal bleeding times
【24h】

The effects of oral administration of Yunnan Baiyao on blood coagulation in beagle dogs as measured by kaolin-activated thromboelastography and buccal mucosal bleeding times

机译:高岭土激活血栓弹力图和颊粘膜出血时间对云南白药口服给药对比格犬血液凝固的影响

获取原文

摘要

We examined the effects of oral administration of Yunnan Baiyao (YB) on hemostasis by measuring buccal mucosal bleeding times (BMBTs) and doing citrated kaolin-activated whole-blood thromboelastography (TEG). In a randomized controlled crossover trial 8 beagle dogs were given either placebo or 1000 mg of YB orally every 12 h for 5 consecutive treatments. Blood was drawn 24 h before treatment and 2 and 24 h after the last treatment, and the BMBT was measured in each sample in duplicate. The TEG analysis was done in duplicate 60 ± 5 min after sample collection. There were no adverse effects of treatment and no significant differences between the control and treatment BMBTs or TEG parameters at any time point. Significant differences were found between baseline and 24 h after the last treatment within the treatment group for the TEG parameters LY30 and LY60 and within the control group for the TEG parameters MA, G, LY30, and LY60. Thus, at the dose and frequency of administration in this study YB did not appear to have any clinically significant effects on the measured coagulation parameters. The differences within the treatment group were likely due to analytic error since similar differences were seen in the control group. Further studies with a larger sample, as well as more direct measures of platelet function, are needed.
机译:我们通过测量颊黏膜出血时间(BMBT)和柠檬酸高岭土活化全血血栓弹性成像(TEG),检查了口服云南白药(YB)对止血的影响。在随机对照试验中,每12小时给8只比格犬口服安慰剂或1000 mg YB,连续5次治疗。在治疗前24小时以及最后一次治疗后2和24小时采血,一式两份测量每个样品的BMBT。样品收集后60±5分钟重复进行TEG分析。在任何时间点,治疗均无不良反应,对照组和治疗组BMBT或TEG参数之间也无明显差异。对于TEG参数LY30和LY60,在治疗组内基线和最后一次治疗后24小时之间,对于TEG参数MA,G,LY30和LY60,在对照组内发现了显着差异。因此,在这项研究的给药剂量和频率下,YB似乎对测定的凝血参数没有任何临床显着影响。治疗组内的差异很可能是由于分析误差所致,因为在对照组中看到了相似的差异。需要对更大的样本进行进一步的研究,以及对血小板功能进行更直接的测量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号